Clinical Trial: An Open-Label Study Of Lamictal In Neurotic Excoriation

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Open-Label Study of Lamictal In Neurotic Excoriation

Brief Summary: The goal of the proposed study is to evaluate the efficacy and safety of Lamictal in neurotic excoriation. Twenty subjects with neurotic excoriation will receive 12 weeks of open-label treatment with Lamictal. The hypothesis to be tested is that Lamictal will be effective and well tolerated in patients with neurotic excoriation. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

Detailed Summary:
Sponsor: University of Minnesota - Clinical and Translational Science Institute

Current Primary Outcome: Yale-Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation

Original Primary Outcome: Same as current

Current Secondary Outcome: Skin Picking Symptom Assessment Scale (SP-SAS) and the Clinical Global Impression scale

Original Secondary Outcome: Same as current

Information By: University of Minnesota - Clinical and Translational Science Institute

Dates:
Date Received: December 22, 2005
Date Started: January 2006
Date Completion:
Last Updated: April 27, 2007
Last Verified: April 2007